ZVS-106e

N/A

Report date: 2026/04/17 20:02:02

Base Information

Drug NameZVS-106e
Drug Alias NameZVS-106eZVS106e
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionGene transference
TargetsUpdating
Therapy Area/IndicationsStargardt Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBeijing Chinagene Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Chinagene Technology Co LtdZhongshan Ophthalmic Center Sun Yat-Sen University
Inactive CompaniesN/A
Active IndicationsStargardt Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A